Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Casa di Cura San Feliciano operates as a leading private multispecialty medical center in Rome with over 40 years of experience. It provides high-quality diagnostic and therapeutic services across orthopedics/traumatology (notably joint surgery), otorhinolaryngology (ENT), nephrology/dialysis care, imaging diagnostics and laboratory analysis. The clinic has established itself as an orthopedic excellence center in the Lazio region with high surgical volumes and advanced rehabilitation programs. It also offers outpatient specialist visits and day-hospital interventions.
No clinical trial pipeline exists as it does not develop drugs or devices.
The clinic collaborates with Italy’s National Health Service for some services.
During the COVID pandemic it implemented enhanced safety protocols.
Laboratory uses modern automated analyzers for diagnostics.
No evidence of drug development or biotech R&D activities.
Revenue estimated at $31.69M USD annually.
Key person listed as Luca Paganini (President).
Main locations are two clinics in western Rome.
No stock symbol; privately held.
No known major pharma/biotech partnerships; focus on patient care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on San Feliciano.